Segment and Geographical Information (Tables)

3 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Segment Revenue, Operating Income (Loss) and Depreciation and Amortization

The tables below present segment revenue, operating income (loss) and depreciation and amortization, as follows:

	Three Months Ended
	December 31,
(Dollars in thousands)	2018			2017
Revenue:
Medical Device	$	17,258		$	12,774
In Vitro Diagnostics		4,983			4,239
Total revenue	$	22,241		$	17,013
Operating income (loss):
Medical Device	$	357		$	(389	)
In Vitro Diagnostics		2,455			1,670
Total segment operating income		2,812			1,281
Corporate		(2,100	)		(1,914	)
Total operating income (loss)	$	712		$	(633	)
Depreciation and amortization:
Medical Device	$	1,388		$	1,272
In Vitro Diagnostics		116			90
Corporate		252			158
Total depreciation and amortization	$	1,756		$	1,520